Providing early cancer detection

As a global leader in biotechnology and molecular diagnostics, Exact Sciences utilizes advanced science, a rigorous process, and an open-minded approach to develop life-changing innovations in early colon cancer detection and treatment options. Their groundbreaking research and pioneering pipeline efforts have led to a robust scientific platform of proprietary technology, including the company's flagship precancer and cancer screening test, Cologuard®.

Comprised of two buildings – a state-of-the-art clinical laboratory and cGMP production laboratory/manufacturing facility – Exact Sciences' expanded Discovery Campus provides capacity to process up to seven million Cologuard tests per year. Flad programmed and planned nearly 60,000 square feet of clinical laboratory space in building one, which supports specimen processing, DNA capture, molecular processing, amplification, and equipment training. The 59,000-square-foot cGMP production laboratory supports manufacturing and processing, as well as filling, kitting, quality control, and tech transfer functions.

As an organization dedicated to continuous process improvement, a key highlight of the project included extensive analysis of process flows to evaluate personnel, samples, materials, and waste movement within the building. As a result of this analysis, the design team was able to provide flexibility that allowed Exact Sciences to seamlessly incorporate improvement initiatives – including automation, equipment upgrades, and expansion opportunities – that maximize operational efficiency, enhance overall productivity, and increase safety.